Zymeworks Provides Corporate Update and Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Zymeworks (ZYME) Tops Q1 EPS by 48c
May 4, 2022 4:38 PM EDTZymeworks (NYSE: ZYME) reported Q1 EPS of ($1.19), $0.48 better than the analyst estimate of ($1.67). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $3.47 million.
For earnings history and earnings-related data on Zymeworks (ZYME) click here.
... More